Africa Malaria Treatment Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 51.35 million |
 Market Size (Forecast Year) |
USD 64.78 million |
 CAGR |
% |
| Major Markets Players |
Africa Malaria Treatment Market, By Agent (Plasmodium Falciparum, P.Vivax, P.Ovale, P.Malariae, P.Knowlelsi), Type (Medication, Vaccination, Others), Treatment Type (Suppressive Treatment, Radical Treatment), Drug Type (Generics, Branded), Route of Administration (Oral, Parenteral), End User (Hospitals, Specialty Clinics, Home Healthcare, Others), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) – Industry Trends and Forecast to 2031.
Africa Malaria Treatment Market Analysis and Size
Malaria is an infectious disease, which spreads through a bite of an infected female Anopheles mosquito, transferring parasites into the human body. Furthermore, these parasites lodge into liver cells, where they multiply and grow. The major factors that drive the Africa malaria treatment market are the increase in awareness initiatives by governments and the surge in research for new antimalarial drugs. However, lack of awareness about healthcare in developing countries is a major factor restraining market growth. An increase in the production, import, and export of hydroxychloroquine and chloroquine is expected to act as an opportunity for the market. Adverse effects and risks associated with anti-malaria drugs are expected to act as a challenge for the market.
Data Bridge Market Research analyzes that the Africa malaria treatment market, which was USD 51.35 million in 2023, is likely to reach USD 64.78 million by 2031 and is expected to undergo a CAGR of 6.4% during the forecast period. “Vaccination” dominates the type segment of the malaria treatment market due to the rising focus on vaccination programs and campaigns. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2024 to 2031 |
|
Base Year |
2023 |
|
Historic Years |
2022 (Customizable to 2016-2021) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Agent (Plasmodium Falciparum, P.Vivax, P.Ovale, P.Malariae, P.Knowlelsi), Type (Medication, Vaccination, Others), Treatment Type (Suppressive Treatment, Radical Treatment), Drug Type (Generics, Branded), Route of Administration (Oral, Parenteral), End User (Hospitals, Specialty Clinics, Home Healthcare, Others), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) |
|
Countries Covered |
Nigeria, Democratic Republic of the Congo, Uganda, Niger, Côte d’Ivoire, Kenya, South Africa, Egypt, Rest of Africa |
|
Market Players Covered |
Hikma Pharmaceuticals PLC (U.K.), Sun Pharmaceutical Industries Ltd. (India), Zydus Cadila (India), Cipla Inc. (India), GlaxoSmithKline plc. (U.K.), Bliss GVS Pharma Ltd. (India), MMV (Switzerland), Novartis AG (Awitzerland), Taj Pharmaceuticals Limited (India), Lupin Pharmaceuticals, Inc. (A Subsidiary of Lupin Limited) (India), AJANTA PHARMA (India), Strides Pharma Science Limited (India), sanofi-aventis U.S. LLC (A Subsidiary of Sanofi) (France), Viatris Inc. (U.S.) |
|
Market Opportunities |
|
Market Definition
Malaria treatment involves a multi-pronged approach aimed at combating the parasitic infection caused by Plasmodium species transmitted through mosquito bites. The primary goal is to eliminate the parasites from the bloodstream and prevent complications. Typically, antimalarial medications are employed based on the species of the parasite and the severity of the infection. Artemisinin-based combination therapies (ACTs) are often the frontline drugs due to their efficacy in targeting the parasite's lifecycle. Other medications such as chloroquine, quinine, or atovaquone-proguanil might be used depending on drug resistance patterns.
Africa Malaria Treatment Market Dynamics
Drivers
- Rising technological advancements
Advances in technology, such as improved diagnostic tools and innovative treatment approaches, drive progress in malaria treatment. Access to rapid diagnostic tests (RDTs), point-of-care devices, and mobile health solutions can revolutionize the diagnosis and management of malaria.
- Improved healthcare infrastructure
Strengthening healthcare infrastructure, especially in underserved rural areas, presents an opportunity to enhance access to quality healthcare services. Building clinics, training healthcare workers, and ensuring the availability of essential medical supplies can significantly impact malaria treatment outcomes.
Opportunities
- Innovation in drug development
There's an opportunity for pharmaceutical companies and researchers to develop new, more effective antimalarial drugs. Investing in research and development can lead to the discovery of novel compounds that combat drug-resistant strains and have fewer side effects, potentially revolutionizing malaria treatment.
- Increasing public private partnerships
Collaboration between governments, non-governmental organizations, philanthropic foundations, and private companies presents an opportunity to pool resources and expertise. Public-private partnerships can facilitate funding for research, infrastructure development, and the distribution of medications and mosquito control measures.
Restraints
- Regulatory approvals and compliance
Regulatory bodies in African countries are responsible for approving and registering medications, ensuring they meet safety and efficacy standards. However, varying regulatory frameworks across different countries can create hurdles for pharmaceutical companies aiming to introduce new drugs to multiple markets simultaneously. Delays in approvals impact the availability of potentially beneficial medications.
- Drug resistance
The emergence of drug-resistant strains of the malaria parasite has been a significant hurdle. Resistance to commonly used antimalarial drugs like chloroquine and sulfadoxine-pyrimethamine has complicated treatment and necessitated the adoption of more expensive and complex therapies.
Challenge
- Diagnostic limitations
Accurate and timely diagnosis of malaria is crucial for effective treatment. However, access to reliable diagnostic tools, particularly in remote areas, is a challenge. Rapid diagnostic tests (RDTs) are not always readily available or affordable, leading to misdiagnosis or delayed treatment.
This malaria treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the malaria treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In February 2018, Cipla Ltd. received confirmation of approval from the World Health Organization (WHO) Prequalification Programme for their 100mg rectal artesunate suppositories (RAS). It is for the pre-referral management of severe malaria. It has enhanced the market growth of the company
- In July 2018, Lupin Pharmaceuticals, Inc. announced that its hydroxychloroquine sulfate tablets got approval from USFDA. The approval has accelerated the company's growth trajectory, particularly in the long term, which is anticipated to strengthen its position in the market
Africa Malaria Treatment Market Scope
The Africa malaria treatment market is segmented into seven notable segments based on agent, type, treatment, drug type, route of administration, end user and distribution channel.
Agent
- Plasmodium Falciparum
- P. Vivax
- P. Ovale
- P. Malariae
- P. Knowlelsi.
Type
- Medication
- Vaccination
- Others
Treatment
- Suppressive treatment
- Radical treatment
Drug Type
- Branded
- Generics
Route of Administration
- Oral
- Parenteral
End User
- Hospitals
- Specialty clinics
- Home healthcare
- Others
Distribution Channel
- Direct tender
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
- Others
Malaria Treatment Market Country Analysis/Insights
The Africa malaria treatment market is segmented into seven notable segments based on agent, type, treatment, drug type, route of administration, end user and distribution channel.
The countries covered in the market report are Nigeria, Democratic Republic of Congo, Uganda, Coste D’ Ivoire, Niger, Kenya, Egypt, South Africa, and the rest of Africa.
Nigeria is expected to dominate and grow with the most promising growth due to the rapidly increasing patients and advancements in technology.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of African brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Africa Malaria Treatment Market Share Analysis
The Africa malaria treatment market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the Africa malaria treatment market.
Some of the major players operating in the Africa malaria treatment market are:
- Hikma Pharmaceuticals PLC (U.K.)
- Sun Pharmaceutical Industries Ltd. (India)
- Zydus Cadila (India)
- Cipla Inc. (India)
- GlaxoSmithKline plc. (U.K.)
- Bliss GVS Pharma Ltd. (India)
- MMV (Switzerland)
- Novartis AG (Awitzerland)
- Taj Pharmaceuticals Limited (India)
- Lupin Pharmaceuticals, Inc. (A Subsidiary of Lupin Limited) (India)
- AJANTA PHARMA (India)
- Strides Pharma Science Limited (India)
- sanofi-aventis U.S. LLC (A Subsidiary of Sanofi) (France)
- Viatris Inc. (U.S.)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of AFRICA MALARIA TREATMENT MARKET
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- PRODUCT type LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- market end user coverage grid
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- premium insights
- AFRICA MALARIA TREATMENT MARKET: REGULATIONS
- Summary write-up (Africa)
- Pipeline analysis
- Market Overview
- Drivers
- High prevalence and disease burden of malaria in Africa
- Rise in medical insurance
- Humid climatic conditions and rising number of mosquitoES (Anopheles gambiae complex) in certain parts of Africa
- Restraints
- Adverse effects and risks associated with antimalariaL drugs
- Lack of awareness related to symptoms of malaria
- Low economic growth, underdeveloped healthcare infrastructure, and lack of access to advanced treatment
- OpportunitIES
- strategic initiatives by major players
- increasing launch of new products
- Increase in production and export as well as import of hydroxychloroquine and chloroquine
- Challenges
- Regulatory challenges to antimalarial drug approval
- Achieving universal access
- COVID-19 IMPACT ON THE AFRICA MALARIA TREATMENT MARKET
- PRICE IMPACT
- IMPACT ON SUPPLY CHAIN
- IMPACT ON DEMAND
- STRATEGIC DECISIONS FOR MANUFACTURERS
- CONCLUSION
- africa malaria treatment MARKET, By agent
- overview
- Plasmodium Falciparum
- P. Vivax
- P. Ovale
- P. Malariae
- P. Knowlelsi
- AFRICA MALARIA TREATMENT MARKET, By type
- overview
- medication
- Chloroquine
- Primaquine
- Artemisinin-Based Combination Therapy (ACT)
- ARTEMETHER–LUMEFANTRINE
- ARTESUNATE-AMODIAQUINE
- DIHYDROARTEMISININ-PIPERAQUINE
- OTHERS
- Quinine
- Hydroxychloroquine
- Mefloquine
- Non-Artemisinin Based Combinations (Non-ACTs)
- SULFADOXINE-PYRIMETHAMINE WITH CHLOROQUINE
- SULFADOXINE-PYRIMETHAMINE WITH AMODIAQUINE
- OTHERS
- Others
- vaccination
- Rts,S/As01
- Pfspz
- Others
- AFRICA MALARIA TREATMENT MARKET, By treatment type
- overview
- Suppressive Treatment
- Radical Treatment
- AFRICA MALARIA TREATMENT MARKET, By Drug Type
- overview
- generics
- branded
- Artefan
- Coartem
- Riamet
- Malarone
- Eurartesim
- Lonart
- Others
- AFRICA MALARIA TREATMENT MARKET, By route of administration
- overview
- oral
- Parenteral
- Intravenous
- Intramuscular
- Subcutaneous
- AFRICA MALARIA TREATMENT MARKET, By end user
- overview
- hospitals
- Specialty Clinics
- Home Healthcare
- others
- AFRICA MALARIA TREATMENT MARKET, By distribution channel
- overview
- direct tender
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Africa malaria treatment market, BY Country
- NIGERIA
- DEMOCRATIC REPUBLIC OF THE CONGO
- UGANDA
- NIGER
- CÔTE D’IVOIRE
- KENYA
- SOUTH AFRICA
- EGYPT
- REST OF AFRICA
- Africa MALARIA TREATMENT Market: COMPANY landscape
- company share analysis: Africa
- swot analysis
- company profile
- Novartis AG
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- cipla inc.
- COMPANY SNAPSHOT
- Revenue analysis
- company share analysis
- product portfolio
- RECENT DEVELOPMENTS
- Strides Pharma Science Limited
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Hikma Pharmaceuticals PLC
- COMPANY SNAPSHOT
- revenue analysis
- company share analysis
- PRODUCT PORTFOLIO
- Recent development
- Sun Pharmaceutical Industries Ltd.
- COMPANY SNAPSHOT
- Revenue analysis
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- AJANTA PHARMA.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Bliss GVS Pharma Ltd.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- GlaxoSmithKline plc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Lupin Pharmaceuticals, Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- MMV
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- sanofi-aventis U.S. LLC.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Taj Pharmaceuticals Limited
- COMPANY SNAPSHOT
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Viatris Inc.
- COMPANY SNAPSHOT
- Revenue analysis
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Zydus Cadila
- COMPANY SNAPSHOT
- revenue analysis
- company share analysis
- PRODUCT PORTFOLIO
- Recent development
- questionnaire
- related reports
List of Table
TABLE 1 Africa malaria treatment Market, pipeline analysis
TABLE 2 ESTIMATED Malaria Cases and Deaths, by Region, 2018
TABLE 3 Regulatory Challenges to Antimalarial Drug Approval.
TABLE 4 Challenges and problems that drive the R&D framework
TABLE 5 AFRICA MALARIA TREATMENT MARKET, By Agent, 2019-2028 (USD thousand)
TABLE 6 Africa Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 7 Africa Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 8 Africa Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 9 Africa Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 10 Africa Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 11 Africa Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)
TABLE 12 Africa Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 13 Africa Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 14 Africa Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 15 Africa Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 16 Africa Malaria Treatment Market, By End User, 2019-2028 (USD Thousand)
TABLE 17 Africa Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)
TABLE 18 Africa Malaria treatment Market, By country, 2019-2028 (USD Thousand)
TABLE 19 Nigeria Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)
TABLE 20 Nigeria Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 21 Nigeria Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 22 Nigeria Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 23 Nigeria Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 24 Nigeria Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 25 Nigeria Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)
TABLE 26 Nigeria Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 27 Nigeria Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 28 Nigeria Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 29 Nigeria Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 30 Nigeria Malaria Treatment Market, By End User 2019-2028 (USD Thousand)
TABLE 31 Nigeria Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)
TABLE 32 Democratic Republic of the Congo Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)
TABLE 33 Democratic Republic of the Congo Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 34 Democratic Republic of the Congo Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 35 Democratic Republic of the Congo Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 36 Democratic Republic of the Congo Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 37 Democratic Republic of the Congo Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 38 Democratic Republic of the Congo Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)
TABLE 39 Democratic Republic of the Congo Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 40 Democratic Republic of the Congo Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 41 Democratic Republic of the Congo Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 42 Democratic Republic of the Congo Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 43 Democratic Republic of the Congo Malaria Treatment Market, By End User, 2019-2028 (USD Thousand)
TABLE 44 Democratic Republic of the Congo Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)
TABLE 45 Uganda Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)
TABLE 46 Uganda Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 47 Uganda Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 48 Uganda Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 49 Uganda Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 50 Uganda Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 51 Uganda Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)
TABLE 52 Uganda Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 53 Uganda Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 54 Uganda Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 55 Uganda Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 56 Uganda Malaria Treatment Market, By End User 2019-2028 (USD Thousand)
TABLE 57 Uganda Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)
TABLE 58 Niger Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)
TABLE 59 Niger Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 60 Niger Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 61 Niger Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 62 Niger Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 63 Niger Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 64 Niger Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)
TABLE 65 Niger Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 66 Niger Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 67 Niger Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 68 Niger Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 69 Niger Malaria Treatment Market, By End User 2019-2028 (USD Thousand)
TABLE 70 Niger Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)
TABLE 71 Côte d’Ivoire Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)
TABLE 72 Côte d’Ivoire Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 73 Côte d’Ivoire Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 74 Côte d’Ivoire Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 75 Côte d’Ivoire Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 76 Côte d’Ivoire Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 77 Côte d’Ivoire Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)
TABLE 78 Côte d’Ivoire Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 79 Côte d’Ivoire Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 80 Côte d’Ivoire Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 81 Côte d’Ivoire Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 82 Côte d’Ivoire Malaria Treatment Market, By End User 2019-2028 (USD Thousand)
TABLE 83 Côte d’Ivoire Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)
TABLE 84 Kenya Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)
TABLE 85 Kenya Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 86 Kenya Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 87 Kenya Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 88 Kenya Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 89 Kenya Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 90 Kenya Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)
TABLE 91 Kenya Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 92 Kenya Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 93 Kenya Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 94 Kenya Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 95 Kenya Malaria Treatment Market, By End User 2019-2028 (USD Thousand)
TABLE 96 Kenya Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)
TABLE 97 South Africa Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)
TABLE 98 South Africa Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 99 South Africa Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 100 South Africa Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 101 South Africa Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 102 South Africa Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 103 South Africa Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)
TABLE 104 South Africa Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 105 South Africa Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 106 South Africa Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 107 South Africa Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 108 South Africa Malaria Treatment Market, By End User 2019-2028 (USD Thousand)
TABLE 109 South Africa Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)
TABLE 110 Egypt Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)
TABLE 111 Egypt Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 112 Egypt Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 113 Egypt Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 114 Egypt Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 115 Egypt Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)
TABLE 116 Egypt Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)
TABLE 117 Egypt Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 118 Egypt Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)
TABLE 119 Egypt Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 120 Egypt Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)
TABLE 121 Egypt Malaria Treatment Market, By End User 2019-2028 (USD Thousand)
TABLE 122 Egypt Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)
TABLE 123 Rest of Africa Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)
List of Figure
FIGURE 1 Africa malaria treatment MARKET: segmentation
FIGURE 2 AFRICA MALARIA TREATMENT MARKET: data triangulation
FIGURE 3 AFRICA MALARIA TREATMENT MARKET: DROC ANALYSIS
FIGURE 4 AFRICA MALARIA TREATMENT MARKET: REGIONAL vs COUNTRY MARKET ANALYSIS
FIGURE 5 AFRICA MALARIA TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 AFRICA MALARIA TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 AFRICA MALARIA TREATMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 8 AFRICA MALARIA TREATMENT MARKET: MARKET end user COVERAGE GRID
FIGURE 9 AFRICA MALARIA TREATMENT MARKET: vendor share analysis
FIGURE 10 AFRICA MALARIA TREATMENT MARKET: SEGMENTATION
FIGURE 11 increasing prevalence of MALARIA, RISING MEDICAL HEALTHCARE INSURANCE, AND humid climatic conditions in africa are expected to drive THE AFRICA MALARIA TREATMENT MARKET IN THE FORECAST PERIOD of 2021 to 2028
FIGURE 12 Plasmodium Falciparum segment is expected to account for the largest share of the AFRICA MALARIA TREATMENT MARKET in 2021 and 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF AFRICA MALARIA TREATMENT MARKET
FIGURE 14 Malaria Cases in 10 highest-burden countries in Africa, 2010-2017
FIGURE 15 AFRICA MALARIA TREATMENT MARKET: By AGENT, 2020
FIGURE 16 AFRICA MALARIA TREATMENT MARKET: By AGENT, 2019-2028 (USD thousand)
FIGURE 17 AFRICA MALARIA TREATMENT MARKET: By AGENT, CAGR (2021-2028)
FIGURE 18 AFRICA MALARIA TREATMENT MARKET: By AGENT, LIFELINE CURVE
FIGURE 19 AFRICA MALARIA TREATMENT MARKET: By type, 2020
FIGURE 20 AFRICA MALARIA TREATMENT MARKET: By type, 2019-2028 (USD thousand)
FIGURE 21 AFRICA MALARIA TREATMENT MARKET: By type, CAGR (2021-2028)
FIGURE 22 AFRICA MALARIA TREATMENT MARKET: By type, LIFELINE CURVE
FIGURE 23 AFRICA MALARIA TREATMENT MARKET: TREATMENT TYPE, 2020
FIGURE 24 AFRICA MALARIA TREATMENT MARKET: TREATMENT TYPE, 2019-2028 (USD thousand)
FIGURE 25 AFRICA MALARIA TREATMENT MARKET: TREATMENT TYPE, CAGR (2021-2028)
FIGURE 26 AFRICA MALARIA TREATMENT MARKET: TREATMENT TYPE, LIFELINE CURVE
FIGURE 27 AFRICA MALARIA TREATMENT MARKET: By drug type, 2020
FIGURE 28 AFRICA MALARIA TREATMENT MARKET: By drug type, 2019-2028 (USD thousand)
FIGURE 29 AFRICA MALARIA TREATMENT MARKET: By drug type, CAGR (2021-2028)
FIGURE 30 AFRICA MALARIA TREATMENT MARKET: By drug type, LIFELINE CURVE
FIGURE 31 AFRICA MALARIA TREATMENT MARKET: By route of administration, 2020
FIGURE 32 AFRICA MALARIA TREATMENT MARKET: By route of administration, 2019-2028 (USD thousand)
FIGURE 33 AFRICA MALARIA TREATMENT MARKET: By route of administration, CAGR (2021-2028)
FIGURE 34 AFRICA MALARIA TREATMENT MARKET: By route of administration, LIFELINE CURVE
FIGURE 35 AFRICA MALARIA TREATMENT MARKET: By end user, 2020
FIGURE 36 AFRICA MALARIA TREATMENT MARKET: By end user, 2019-2028 (USD thousand)
FIGURE 37 AFRICA MALARIA TREATMENT MARKET: By end user, CAGR (2021-2028)
FIGURE 38 AFRICA MALARIA TREATMENT MARKET: By end user, LIFELINE CURVE
FIGURE 39 AFRICA MALARIA TREATMENT MARKET: By DISTRIBUTION CHANNEL, 2020
FIGURE 40 AFRICA MALARIA TREATMENT MARKET: By DISTRIBUTION CHANNEL, 2019-2028 (USD thousand)
FIGURE 41 AFRICA MALARIA TREATMENT MARKET: By DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 42 AFRICA MALARIA TREATMENT MARKET: By DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 43 Africa Malaria treatment MARKET: SNAPSHOT (2020)
FIGURE 44 Africa Malaria treatment MARKET: BY COUNTRY (2020)
FIGURE 45 Africa Malaria treatment MARKET: BY COUNTRY (2021 & 2028)
FIGURE 46 Africa Malaria treatment MARKET: BY COUNTRY (2020 & 2028)
FIGURE 47 Africa Malaria treatment MARKET: BY Agent (2021-2028)
FIGURE 48 Africa MALARIA TREATMENT Market: company share 2020 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
